116 related articles for article (PubMed ID: 27042179)
1. Correlation of Beta-2 Adrenergic Receptor Expression in Tumor-Free Surgical Margin and at the Invasive Front of Oral Squamous Cell Carcinoma.
Oliveira DT; Bravo-Calderón DM; Lauand GA; Assao A; Suárez-Peñaranda JM; Pérez-Sayáns M; García-García A; Marana AN; Nonogaki S; Lauris JR; Kowalski LP
J Oncol; 2016; 2016():3531274. PubMed ID: 27042179
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of β-Adrenergic Receptors and the Suppressive Effect of β
Zhang C; Liao X; Ma Z; Liu S; Fang F; Mai H
J Oral Maxillofac Surg; 2020 Oct; 78(10):1871.e1-1871.e23. PubMed ID: 32640209
[TBL] [Abstract][Full Text] [Related]
4. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma.
Shang ZJ; Liu K; Liang DF
J Oral Pathol Med; 2009 Apr; 38(4):371-6. PubMed ID: 19141064
[TBL] [Abstract][Full Text] [Related]
5. Expression of beta adrenergic receptor in oral squamous cell carcinoma and its significance to the prognosis.
Dong H; Liao XX; Mai HM; Zhou N; Wang DY; Peng JB; Yang LH
Int J Clin Exp Pathol; 2017; 10(10):10431-10440. PubMed ID: 31966380
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target.
Krishna A; Singh V; Singh N; Singh S; Mohanty SK; Singh R; Kumar V; Singh US; Singh RK
Clin Transl Oncol; 2022 Nov; 24(11):2191-2199. PubMed ID: 35918593
[TBL] [Abstract][Full Text] [Related]
7. Expression of β
Santos-Sousa AL; Kayahara GM; Bastos DB; Sarafim-Silva BAM; Crivelini MM; Valente VB; Corrente JE; Xavier-Júnior JCC; Miyahara GI; Bernabé DG
Arch Oral Biol; 2024 Jun; 162():105939. PubMed ID: 38490087
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 at invasive front of oral squamous cell carcinoma and negative histopathological surgical margins to establish correlation at 3-year survival.
Gawande M; Chaudhary M; Sharma P; Hande A; Patil S; Sonone A
J Oral Maxillofac Pathol; 2020; 24(3):582. PubMed ID: 33967511
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
10. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
[No Abstract] [Full Text] [Related]
11. Effects of FasL expression in oral squamous cell cancer.
Fang L; Sun L; Hu FF; Chen QE
Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-like weak inducer of apoptosis expression in healthy oral mucosa, oral dysplasia and oral squamous cell carcinoma.
Acharya S; Prabhu P; Patil V; Acharya AB; Desai A; Nikhil K
J Oral Maxillofac Pathol; 2019; 23(3):369-377. PubMed ID: 31942116
[TBL] [Abstract][Full Text] [Related]
13. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
14. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas].
Liu LK; Li YN; Jiang HB; He ZX; Yi XZ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788
[TBL] [Abstract][Full Text] [Related]
15. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
16. CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis.
Okuyama K; Fukushima H; Naruse T; Yanamoto S; Tsuchihashi H; Umeda M
Pathol Oncol Res; 2019 Apr; 25(2):603-609. PubMed ID: 30387013
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-17 with tumor budding as a prognostic marker in oral squamous cell carcinoma.
Zhang S; Wang X; Gupta A; Fang X; Wang L; Zhang C
Am J Transl Res; 2019; 11(3):1876-1883. PubMed ID: 30972211
[TBL] [Abstract][Full Text] [Related]
18. Association of alpha2a and beta2 adrenoceptor expression with clinical outcome in breast cancer.
Du Y; Zhou L; Wang Y; Yan T; Jiang Y; Shao Z; Yin W; Lu J
Curr Med Res Opin; 2014 Jul; 30(7):1337-44. PubMed ID: 24559182
[TBL] [Abstract][Full Text] [Related]
19. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and matrix metalloproteinase-9 in oral squamous cell carcinoma and histologically negative surgical margins and association with clinicopathological parameters.
Mohtasham N; Anvari K; Memar B; Saghravanian N; Ghazi N; Bagherpour A; Ramtin M
Rom J Morphol Embryol; 2014; 55(1):117-21. PubMed ID: 24715175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
